CRA Line Manager ensuring high performance, quality and continuous development. Interviewing evaluating and selecting CRA and CTA. Assist customer in performing oversight in fulfilling its site management activities and obligations in relation to clinical studies as the primary sponsor of those studies. Involve in FSP model. Management 12 to 16 CRAs. FU on high quality customer metrics. study allocation, site visit assessment, monthly client reporting, employees performance review, team… Show more CRA Line Manager ensuring high performance, quality and continuous development. Interviewing evaluating and selecting CRA and CTA. Assist customer in performing oversight in fulfilling its site management activities and obligations in relation to clinical studies as the primary sponsor of those studies. Involve in FSP model. Management 12 to 16 CRAs. FU on high quality customer metrics. study allocation, site visit assessment, monthly client reporting, employees performance review, team building and collective training organisation. Show less

Initiate to close out appropriate investigational sites for clinical studies. Monitor those sites in order to ensure that studies are carried out according to study protocol, customer SOP, applicable regulations and principales of ICH GCP. Become involved when required in other areas of study management, staff training and contribute of the review of DOCS and customer systems and procedures as appropriate. Provide a benchmark of monitoring competence to inexperienced/less experience CRA… Show more Initiate to close out appropriate investigational sites for clinical studies. Monitor those sites in order to ensure that studies are carried out according to study protocol, customer SOP, applicable regulations and principales of ICH GCP. Become involved when required in other areas of study management, staff training and contribute of the review of DOCS and customer systems and procedures as appropriate. Provide a benchmark of monitoring competence to inexperienced/less experience CRA. Therapeutic areas: Haematology/Oncology (ALL, Melanoma, MM, Breast Cancer), Rheumatology (SLE, Rheumatoid Arthritis), Cardiology, Musculoskeletal and Connective Tissue Disorders. Show less

• Site selection visit, SIV, SMV, FMV, IP accountability (FIPRS, ePOR, RIPD), SAE & DoA reconciliation, billing, ICF review, SDV, ODT reconciliation, administrative reconciliation (ISF & IPIM), remote monitoring, IRB/IEC submissions, site staff training, recruitment follow-up, boosting visit for low performer sites, RML collaboration, evaluate the quality and integrity of study site practices, visit reports & follow up letters, eCRF, paper CRF, CTMS, SSU activities, contacts with RA & SCBA… Show more • Site selection visit, SIV, SMV, FMV, IP accountability (FIPRS, ePOR, RIPD), SAE & DoA reconciliation, billing, ICF review, SDV, ODT reconciliation, administrative reconciliation (ISF & IPIM), remote monitoring, IRB/IEC submissions, site staff training, recruitment follow-up, boosting visit for low performer sites, RML collaboration, evaluate the quality and integrity of study site practices, visit reports & follow up letters, eCRF, paper CRF, CTMS, SSU activities, contacts with RA & SCBA, site activation.• Therapeutic areas: Oncology (2 studies in Leukemia (Phase I) & Melanoma (Phase III)), Cardiology (3 studies (Phase III & IV)), Immunology (1 study (Phase I))• Lead CRA for Phase 4 study (200 sites, 1000 subjects). PoC customer/RCTM/team members (15 CRAs & 6 CTAs)• Participation into several Workshops (Oncology, Monitoring Fundamentals, ICF, Remote monitoring, IP, Correspondence, Hospital in France) Show less

Antidotes and innovative solutions against pesticides and chemical warfare poisoning• Design and development of novel antidotes (NCEs in drug discovery)• Coordination of subcontractors (chemists, biologists) and CNRS administrators• Fund-raising, international investors: DGA, Dstl, SATT, BPI France• Contract management and financial statement• StarterClass’ 2015 Laureate, SEMIA, Business Innovative Incubator, France• Recruitment of 2 consultants (Director of Research at… Show more Antidotes and innovative solutions against pesticides and chemical warfare poisoning• Design and development of novel antidotes (NCEs in drug discovery)• Coordination of subcontractors (chemists, biologists) and CNRS administrators• Fund-raising, international investors: DGA, Dstl, SATT, BPI France• Contract management and financial statement• StarterClass’ 2015 Laureate, SEMIA, Business Innovative Incubator, France• Recruitment of 2 consultants (Director of Research at IRBA and Director of Research at Dstl/Director of the OPCW Scientific committee) Show less

European Project co-funded by the French Army (DGA) and the British Army (Dstl) in a dual programme. Research carried out in collaboration within Prof. Richard C. Brown's group (University of Southampton) and Dr. Rachid Baati's group (University of Strasbourg). Design, Synthesis and Biological Evaluation of Novel Antidote against pesticides and chemical warfare poisoning. • Multi-disciplinary teams’ coordination (chemists, biologists)• Project management: master II, PhD and post-doc… Show more European Project co-funded by the French Army (DGA) and the British Army (Dstl) in a dual programme. Research carried out in collaboration within Prof. Richard C. Brown's group (University of Southampton) and Dr. Rachid Baati's group (University of Strasbourg). Design, Synthesis and Biological Evaluation of Novel Antidote against pesticides and chemical warfare poisoning. • Multi-disciplinary teams’ coordination (chemists, biologists)• Project management: master II, PhD and post-doc projects• Speaker during International Conferences (Alicante, London, Nice)• Teaching: directed exercises and practical training• 1 patent, 7 publications• Thesis awarded with high distinctions Show less

Biological Evaluation of Multivalent Iminosugars for the treatment of Gaucher’s Disease. Carried out within Dr. Terry D. Butters’ group• in vitro assays (IC50, Ki, CC50)• in cellulo assays (Fibroblasts, HL60)

Synthesis of Multivalent Iminosugars as Pharmaceutical Chaperons for the treatment of Gaucher’s Disease. Carried out within Prof. Philippe Compain group (Laboratoire de Synthèse Organique et Molécules Bioactives -UMR CNRS 7509)• Organic synthesis, medicinal chemistry• SAR

Hit Generation Team leading by Dr. Frederik Rombouts• Organic synthesis, medicinal chemistry• FBDD• Homogeneous Catalysis• C-H activation• Heterocyclic chemistry• SAR

Mane Organic Research group• Organic synthesis• Synthesis of Molecules with Organoleptic Properties• Heterocyclic chemistry• Rearrangement• Cycloaddition

Dr. Elisabeth Davioud-Charvet group (UMR CNRS 7509)• Synthesis of Azamenadiones as Precursors of Pesticides• Hetero-Cycloaddition• C-C bond forming reactions